High-dose interleukin-2 (hd-IL2) in treatment-naïve metastatic renal cell carcinoma (mrcc) - a 10 year single-site experience and outcome of prospective pathology-based patient sel...

por Chow, Shien, Evans, Manon, Galvis, Victoria, Leach, Rebecca, Keene, Elizabeth, Chan, Kevin, Spencer-Shaw, Andrea, Jonathan, Shanks, Shabalak, Alaaeldin, Thistlethwaite, Fiona, Hawkins, Robert
Publicado 2014